Prevalence and Spectrum of Germline Mutations of the p53 Gene among Patients with Sarcoma

HEREDITARY mutations of tumor-suppressor genes have been correlated with a genetic predisposition to cancer, and several such genes have been linked to distinct familial cancer syndromes. 1 The best-studied example is retinoblastoma; about 40 percent of the cases are due to germline mutations of the...

Full description

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 326; no. 20; pp. 1301 - 1308
Main Authors Toguchida, Junya, Yamaguchi, Toshikazu, Dayton, Siri H, Beaughamp, Roberta L, Herrera, Guillermo E, Ishizaki, Kanji, Yamamuro, Takao, Meyers, Paul A, Little, John B, Sasaki, Masao S, Weichselbaum, Ralph R, Yandell, David W
Format Journal Article
LanguageEnglish
Published Boston, MA Massachusetts Medical Society 14.05.1992
Subjects
Online AccessGet full text

Cover

Loading…
Abstract HEREDITARY mutations of tumor-suppressor genes have been correlated with a genetic predisposition to cancer, and several such genes have been linked to distinct familial cancer syndromes. 1 The best-studied example is retinoblastoma; about 40 percent of the cases are due to germline mutations of the retinoblastoma gene (the remaining 60 percent of cases are nonhereditary and are due to somatic mutations). 2 Patients with the hereditary form have a high risk of multifocal retinoblastoma and other tumors, and they may pass the disease to their progeny as an autosomal dominant trait. Three fourths of the hereditary cases of retinoblastoma occur in patients . . .
AbstractList BACKGROUNDRecent studies have identified germline mutations of the p53 tumor-suppressor gene in families with the Li-Fraumeni syndrome, a rare inherited disorder characterized by a high risk of sarcomas of bone and soft tissue, breast cancer, and other tumors. In this report, we address the possibility that some sporadic sarcomas may be associated with new germline mutations of the p53 gene, which would not be manifested as familial cancer unless the patient survived to reproduce.METHODSWe studied DNA from peripheral leukocytes of 196 patients with sarcoma and from 200 controls. Of the 196 patients with sarcoma, 15 were selected because they had had multiple primary cancers or had a family history of cancer. The entire coding sequence and splice junctions of the p53 gene were analyzed for mutations.RESULTSEight germline mutations were found, three in patients with no known family history of cancer and five in patients with an unusual personal or family history of cancer. Four mutations caused amino acid substitutions, and four caused stop codons. These mutations were not present in any of the 200 controls.CONCLUSIONSNew germline mutations of the p53 gene are rare among patients with "sporadic" sarcoma but may be common in patients with sarcoma whose background includes either multiple primary cancers or a family history of cancer. Diverse mutations of this gene were associated with an increased likelihood of cancer; hence, the entire gene should be considered a target for heritable mutation. It appears that the group of patients with cancer who carry germline mutations of the p53 gene is more diverse than is suggested by the clinical definition of the Li-Fraumeni syndrome. The identification of carriers could be of substantial clinical importance.
Abstract Background Recent studies have identified germline mutations of the p53 tumor-suppressor gene in families with the Li--Fraumeni syndrome, a rare inherited disorder characterized by a high risk of sarcomas of bone and soft tissue, breast cancer, and other tumors. In this report, we address the possibility that some sporadic sarcomas may be associated with new germline mutations of the p53 gene, which would not be manifested as familial cancer unless the patient survived to reproduce. Methods We studied DNA from peripheral leukocytes of 196 patients with sarcoma and from 200 controls. Of the 196 patients with sarcoma, 15 were selected because they had had multiple primary cancers or had a family history of cancer. The entire coding sequence and splice junctions of the p53 gene were analyzed for mutations. Results Eight germline mutations were found, three in patients with no known family history of cancer and five in patients with an unusual personal or family history of cancer. Four mutations caused amino acid substitutions, and four caused stop codons. These mutations were not present in any of the 200 controls. Conclusions New germline mutations of the p53 gene are rare among patients with "sporadic" sarcoma but may be common in patients with sarcoma whose background includes either multiple primary cancers or a family history of cancer. Diverse mutations of this gene were associated with an increased likelihood of cancer; hence, the entire gene should be considered a target for heritable mutation. It appears that the group of patients with cancer who carry germline mutations of the p53 gene is more diverse than is suggested by the clinical definition of the Li--Fraumeni syndrome. The identification of carriers could be of substantial clinical importance. (N Engl J Med 1992;326: 1301-8.)
We studied DNA from peripheral leukocytes of 196 patients with sarcoma and from 200 controls. Of the 196 patients with sarcoma, 15 were selected because they had had multiple primary cancers or had a family history of cancer. The entire coding sequence and splice junctions of the p53 gene were analyzed for mutations. Eight germline mutations were found, three in patients with no known family history of cancer and five in patients with an unusual personal or family history of cancer. Four mutations caused amino acid substitutions, and four caused stop codons. These mutations were not present in any of the 200 controls.
HEREDITARY mutations of tumor-suppressor genes have been correlated with a genetic predisposition to cancer, and several such genes have been linked to distinct familial cancer syndromes. 1 The best-studied example is retinoblastoma; about 40 percent of the cases are due to germline mutations of the retinoblastoma gene (the remaining 60 percent of cases are nonhereditary and are due to somatic mutations). 2 Patients with the hereditary form have a high risk of multifocal retinoblastoma and other tumors, and they may pass the disease to their progeny as an autosomal dominant trait. Three fourths of the hereditary cases of retinoblastoma occur in patients . . .
Recent studies have identified germline mutations of the p53 tumor-suppressor gene in families with the Li-Fraumeni syndrome, a rare inherited disorder characterized by a high risk of sarcomas of bone and soft tissue, breast cancer, and other tumors. In this report, we address the possibility that some sporadic sarcomas may be associated with new germline mutations of the p53 gene, which would not be manifested as familial cancer unless the patient survived to reproduce. We studied DNA from peripheral leukocytes of 196 patients with sarcoma and from 200 controls. Of the 196 patients with sarcoma, 15 were selected because they had had multiple primary cancers or had a family history of cancer. The entire coding sequence and splice junctions of the p53 gene were analyzed for mutations. Eight germline mutations were found, three in patients with no known family history of cancer and five in patients with an unusual personal or family history of cancer. Four mutations caused amino acid substitutions, and four caused stop codons. These mutations were not present in any of the 200 controls. New germline mutations of the p53 gene are rare among patients with "sporadic" sarcoma but may be common in patients with sarcoma whose background includes either multiple primary cancers or a family history of cancer. Diverse mutations of this gene were associated with an increased likelihood of cancer; hence, the entire gene should be considered a target for heritable mutation. It appears that the group of patients with cancer who carry germline mutations of the p53 gene is more diverse than is suggested by the clinical definition of the Li-Fraumeni syndrome. The identification of carriers could be of substantial clinical importance.
Author Dayton, Siri H
Weichselbaum, Ralph R
Toguchida, Junya
Herrera, Guillermo E
Yamamuro, Takao
Meyers, Paul A
Beaughamp, Roberta L
Little, John B
Yandell, David W
Sasaki, Masao S
Ishizaki, Kanji
Yamaguchi, Toshikazu
Author_xml – sequence: 1
  givenname: Junya
  surname: Toguchida
  fullname: Toguchida, Junya
– sequence: 2
  givenname: Toshikazu
  surname: Yamaguchi
  fullname: Yamaguchi, Toshikazu
– sequence: 3
  givenname: Siri H
  surname: Dayton
  fullname: Dayton, Siri H
– sequence: 4
  givenname: Roberta L
  surname: Beaughamp
  fullname: Beaughamp, Roberta L
– sequence: 5
  givenname: Guillermo E
  surname: Herrera
  fullname: Herrera, Guillermo E
– sequence: 6
  givenname: Kanji
  surname: Ishizaki
  fullname: Ishizaki, Kanji
– sequence: 7
  givenname: Takao
  surname: Yamamuro
  fullname: Yamamuro, Takao
– sequence: 8
  givenname: Paul A
  surname: Meyers
  fullname: Meyers, Paul A
– sequence: 9
  givenname: John B
  surname: Little
  fullname: Little, John B
– sequence: 10
  givenname: Masao S
  surname: Sasaki
  fullname: Sasaki, Masao S
– sequence: 11
  givenname: Ralph R
  surname: Weichselbaum
  fullname: Weichselbaum, Ralph R
– sequence: 12
  givenname: David W
  surname: Yandell
  fullname: Yandell, David W
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4353637$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/1565143$$D View this record in MEDLINE/PubMed
BookMark eNqFkV9rFTEQxYNU6m31E4gQVHyR1SSTZJNHKW1VWi1UH3xacrOzdi-b7G2ya_Hbm-VeFMQ_eUhgzu_MTDhH5CCOEQl5zNkrzpR-_eH0_SW3VjDFJQgtGOP3yIorgEpKpg_IijFhKllbeECOct6wcri0h-SQK72YVuTLVcJvbsDokbrY0ust-inNgY4dPccUhj4ivZwnN_VjzEt1ukG6VVDUorgwxq_0qqgYp0zv-umGXrvkx-AekvudGzI-2r_H5PPZ6aeTt9XFx_N3J28uKq9ATRVgq7y0a0TeosFOScmtEaLVrGtr46xltfTIDFh02rWwFsJoA-WugWsOx-TFru82jbcz5qkJffY4DC7iOOemFsYKLeG_INe6VgZkAZ_-Bm7GOcXyiUYIsLI2qi7Qs79BZX-Q0hi5ULCjfBpzTtg129QHl743nDVLiM0fQiyuJ_ve8zpg-8uzS63oz_e6y94NXXLR9_knJkGBhmX4yx0WQm4ibsI_h_4AgbeuZQ
CODEN NEJMAG
CitedBy_id crossref_primary_10_1016_0304_419X_93_90004_V
crossref_primary_10_1002_jso_23809
crossref_primary_10_1136_jmg_32_12_942
crossref_primary_10_3109_02713689409167295
crossref_primary_10_1111_cas_14919
crossref_primary_10_1097_MPH_0000000000002097
crossref_primary_10_1200_PO_20_00087
crossref_primary_10_1016_S0031_3955_02_00095_0
crossref_primary_10_1016_0749_2081_92_90033_Y
crossref_primary_10_1158_1541_7786_MCR_18_0620
crossref_primary_10_1002_mpo_2950230407
crossref_primary_10_1038_labinvest_3780431
crossref_primary_10_1007_s10147_014_0729_8
crossref_primary_10_1016_0959_8049_94_00383_G
crossref_primary_10_1038_ng1193_225
crossref_primary_10_1002_gcc_2870090203
crossref_primary_10_1016_0145_2126_93_90130_D
crossref_primary_10_1023_A_1014403613747
crossref_primary_10_1016_j_ejca_2009_03_005
crossref_primary_10_1016_0959_8049_95_00121_X
crossref_primary_10_1016_S0748_7983_98_93896_3
crossref_primary_10_1097_00130404_200507000_00005
crossref_primary_10_1002_ijc_21195
crossref_primary_10_1016_S0146_6435_98_00007_3
crossref_primary_10_1038_sj_onc_1204621
crossref_primary_10_1080_15513810009168647
crossref_primary_10_1634_theoncologist_9_4_422
crossref_primary_10_1016_0046_8177_94_90220_8
crossref_primary_10_1002_ijc_2910630312
crossref_primary_10_1016_S0009_8981_96_06442_X
crossref_primary_10_1016_S0889_8588_18_30164_3
crossref_primary_10_1038_sj_bjc_6601748
crossref_primary_10_1002_ssu_2980100503
crossref_primary_10_1002_jso_21763
crossref_primary_10_1002__SICI_1098_1004_1997_9_2_157__AID_HUMU8_3_0_CO_2_6
crossref_primary_10_1016_S0022_5347_01_67517_7
crossref_primary_10_1002_sim_4780130206
crossref_primary_10_1097_00000372_199806000_00015
crossref_primary_10_1002_ijc_20269
crossref_primary_10_1016_S0165_4608_96_00072_6
crossref_primary_10_1016_j_jdcr_2017_11_011
crossref_primary_10_1016_S0165_1110_96_90010_X
crossref_primary_10_1016_S1368_8375_01_00078_1
crossref_primary_10_1007_s00117_022_01071_x
crossref_primary_10_1016_S0022_3476_98_70007_1
crossref_primary_10_1016_0959_8049_93_90023_9
crossref_primary_10_1007_BF02272849
crossref_primary_10_1016_0959_8049_96_00104_9
crossref_primary_10_1002_ijc_29882
crossref_primary_10_1016_S1053_4296_99_80025_3
crossref_primary_10_1111_j_1349_7006_1992_tb02730_x
crossref_primary_10_1038_bjc_2014_263
crossref_primary_10_1016_0027_5107_93_90014_7
crossref_primary_10_1016_0165_4608_93_90166_J
crossref_primary_10_1016_S0889_8588_18_30244_2
crossref_primary_10_1007_s11912_009_0061_z
crossref_primary_10_1016_S0344_0338_96_80090_2
crossref_primary_10_1515_bchm3_1993_374_1_6_227
crossref_primary_10_1097_00003081_199803000_00024
crossref_primary_10_1158_1078_0432_CCR_07_0395
crossref_primary_10_1016_S0303_8467_98_00072_9
crossref_primary_10_1080_17453674_1997_11744704
crossref_primary_10_1002_jso_20720
crossref_primary_10_1016_0140_6736_92_92943_A
crossref_primary_10_1093_jnci_89_22_1706
crossref_primary_10_3389_fonc_2015_00208
crossref_primary_10_1002_humu_1380020407
crossref_primary_10_1002__SICI_1097_0347_199709_19_6_513__AID_HED9_3_0_CO_2_1
crossref_primary_10_1002_hed_20820
crossref_primary_10_1016_j_bbcan_2021_188512
crossref_primary_10_3109_08880019509009482
crossref_primary_10_1016_S0344_0338_11_80599_6
crossref_primary_10_1056_NEJM199307013290105
crossref_primary_10_1002_pbc_24269
crossref_primary_10_1002_jor_1100170503
crossref_primary_10_1007_BF01213553
crossref_primary_10_3389_fonc_2020_554388
crossref_primary_10_1038_ng1093_124
crossref_primary_10_3390_cancers14143503
crossref_primary_10_1016_S0889_8588_18_30082_0
crossref_primary_10_1002_mpo_10060
crossref_primary_10_1111_j_1349_7006_2000_tb01028_x
crossref_primary_10_1002_gcc_2870110309
crossref_primary_10_1002_humu_10185
crossref_primary_10_1002_stem_5530130741
crossref_primary_10_1007_s11626_999_0026_4
crossref_primary_10_1097_CORR_0000000000002745
crossref_primary_10_1158_1078_0432_CCR_16_0610
crossref_primary_10_1186_s12864_017_3895_z
crossref_primary_10_1056_NEJM199205143262008
crossref_primary_10_1111_his_12280
crossref_primary_10_1158_0008_5472_CAN_22_0172
crossref_primary_10_1038_npjgenmed_2015_3
crossref_primary_10_1097_00043426_200305000_00003
crossref_primary_10_1101_mcs_a002246
crossref_primary_10_1111_j_1349_7006_1998_tb00637_x
crossref_primary_10_1186_2045_3329_2_1
crossref_primary_10_1016_S0030_5898_20_32089_7
crossref_primary_10_1038_s41418_022_00980_7
crossref_primary_10_1002_ijc_2910640606
crossref_primary_10_1016_0165_4608_94_90467_7
crossref_primary_10_1002_mpo_2950250612
crossref_primary_10_1093_jnci_90_8_606
crossref_primary_10_1089_dna_1995_14_983
crossref_primary_10_1186_bcr2647
crossref_primary_10_1002_pbc_20700
crossref_primary_10_1136_jmg_35_12_1036
crossref_primary_10_1016_0165_4608_95_00367_3
crossref_primary_10_1016_j_critrevonc_2015_08_019
crossref_primary_10_1016_j_mporth_2016_08_004
crossref_primary_10_1016_0959_8049_93_90001_V
crossref_primary_10_1136_mp_48_5_M221
crossref_primary_10_1016_j_mpsur_2020_06_018
crossref_primary_10_1086_374567
crossref_primary_10_1371_journal_pone_0135074
crossref_primary_10_1007_BF02316809
crossref_primary_10_1093_jnci_djv101
crossref_primary_10_3892_ol_2017_6767
crossref_primary_10_1016_j_canlet_2018_10_033
crossref_primary_10_1007_s12253_014_9836_0
crossref_primary_10_1007_BF02303500
crossref_primary_10_1016_S0344_0338_98_80096_4
crossref_primary_10_1056_NEJM199310283291807
crossref_primary_10_1002__SICI_1096_911X_1996_27_1__25__AID_MPO5_3_0_CO_2_P
crossref_primary_10_1007_BF02990955
crossref_primary_10_1002_jso_2930560218
crossref_primary_10_1002_gepi_1370120103
crossref_primary_10_1007_s11999_008_0335_z
crossref_primary_10_1002_pbc_24213
crossref_primary_10_1002_1097_0142_19930801_72_3_923__AID_CNCR2820720343_3_0_CO_2_Y
crossref_primary_10_1002_ajmg_a_62767
crossref_primary_10_1016_S0272_2712_18_30292_0
crossref_primary_10_1002_cncr_26390
crossref_primary_10_1016_0165_4608_94_00213_U
crossref_primary_10_1007_BF02710274
crossref_primary_10_1016_0304_3835_95_04048_X
crossref_primary_10_1016_0165_4608_93_90233_C
crossref_primary_10_5144_0256_4947_1995_252
crossref_primary_10_1002_ajh_2830450412
crossref_primary_10_1016_0304_3835_93_90187_E
crossref_primary_10_1016_j_ajoms_2019_05_004
crossref_primary_10_1016_S0959_8049_97_00251_7
crossref_primary_10_1038_nrendo_2017_16
crossref_primary_10_6004_jnccn_2021_7034
crossref_primary_10_1016_S0305_7372_98_90001_9
crossref_primary_10_3390_ijms22137160
crossref_primary_10_1111_j_1600_0676_1993_tb00626_x
crossref_primary_10_1016_0009_8981_95_06066_M
crossref_primary_10_1093_carcin_bgq256
crossref_primary_10_3390_cells11223614
crossref_primary_10_1200_JCO_2005_10_042
crossref_primary_10_14789_jmj_JMJ22_0012_CR
crossref_primary_10_1016_0165_4608_96_00071_4
crossref_primary_10_1016_S0338_9898_96_80030_8
crossref_primary_10_1371_journal_pone_0069026
crossref_primary_10_5694_j_1326_5377_1992_tb137441_x
crossref_primary_10_1002_1097_0215_19960208_65_4_554__AID_IJC2910650402_3_0_CO_2_U
crossref_primary_10_1016_S0165_4608_03_00105_5
crossref_primary_10_1002__SICI_1096_911X_199709_29_3_206__AID_MPO7_3_0_CO_2_H
crossref_primary_10_1111_1346_8138_15488
crossref_primary_10_1136_bjo_77_10_662
crossref_primary_10_1002_cncr_31212
Cites_doi 10.1128/MCB.7.2.961
10.1038/348747a0
10.1016/S0161-6420(84)34127-6
10.1038/278261a0
10.1126/science.1978757
10.1126/science.2999980
10.1126/science.2144364
10.1016/0092-8674(91)90384-B
10.1056/NEJM198512263132605
10.1200/JCO.1990.8.3.443
10.1038/314633a0
10.1128/JVI.63.2.739-746.1989
10.1016/0888-7543(89)90129-8
10.1073/pnas.88.17.7825
10.1001/archopht.1990.01070030134045
10.1073/pnas.87.15.5863
10.1126/science.2144363
10.1038/342705a0
10.1073/pnas.84.21.7716
10.1126/science.2047879
10.1016/0092-8674(89)90045-7
10.1128/JVI.62.12.4737-4744.1988
10.1073/pnas.86.17.6783
10.1126/science.2144057
10.1007/BF00295569
10.1093/jnci/83.13.938
10.1073/pnas.74.3.1245
ContentType Journal Article
Copyright 1993 INIST-CNRS
Copyright Massachusetts Medical Society May 14, 1992
Copyright Massachusetts Medical Society, Publishing Division May 14, 1992
Copyright_xml – notice: 1993 INIST-CNRS
– notice: Copyright Massachusetts Medical Society May 14, 1992
– notice: Copyright Massachusetts Medical Society, Publishing Division May 14, 1992
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
0TZ
7RV
7X7
7XB
8AO
8C1
8FE
8FH
8FI
ABUWG
AFKRA
AN0
AZQEC
BBNVY
BEC
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
K0Y
LK8
M0R
M0T
M1P
M2M
M2O
M2P
M7P
MBDVC
NAPCQ
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7T3
7TO
8FD
FR3
H94
P64
RC3
7X8
DOI 10.1056/NEJM199205143262001
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Pharma and Biotech Premium PRO
ProQuest Nursing & Allied Health Database
ProQuest_Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest Pharma Collection
ProQuest Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
ProQuest Central (Alumni)
ProQuest Central
British Nursing Database
ProQuest Central Essentials
Biological Science Collection
eLibrary
AUTh Library subscriptions: ProQuest Central
ProQuest Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
SciTech Premium Collection (Proquest) (PQ_SDU_P3)
New England Journal of Medicine
Biological Sciences
ProQuest Consumer Health Database
ProQuest Healthcare Administration Database
PML(ProQuest Medical Library)
Psychology Database (ProQuest)
ProQuest research library
ProQuest Science Journals
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
Human Genome Abstracts
Oncogenes and Growth Factors Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest One Psychology
Pharma and Biotech Premium PRO
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
elibrary
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
New England Journal of Medicine
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Research Library
ProQuest Public Health
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest Family Health
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
ProQuest Health Management
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
Human Genome Abstracts
Genetics Abstracts
Oncogenes and Growth Factors Abstracts
Technology Research Database
AIDS and Cancer Research Abstracts
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
ProQuest One Psychology
Human Genome Abstracts

MEDLINE
ProQuest One Psychology
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: AUTh Library subscriptions: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1533-4406
EndPage 1308
ExternalDocumentID 2836466
10_1056_NEJM199205143262001
1565143
4353637
NJ199205143262001
Genre Original Article
Research Support, U.S. Gov't, P.H.S
Research Support, Non-U.S. Gov't
Journal Article
Case Reports
General Information
GeographicLocations United States
Japan
GeographicLocations_xml – name: Japan
– name: United States
GroupedDBID -
08R
0R
0WA
123
186
1KJ
1VV
2KS
2WC
34G
3O-
3V.
4
4.4
53G
55
5D0
5RE
7FN
7RV
7X7
85S
8AO
8C1
8FE
8FH
8FI
8RP
8WZ
A6W
AACLI
AAEJM
AAIKC
AALRV
AAPBV
AAQQT
AARDX
AASXA
AAUTI
AAWTL
ABACO
ABEHJ
ABFLS
ABIVO
ABOCM
ABPPZ
ABPTK
ABQES
ABQIJ
ABUFD
ABUWG
ABWJO
ACGFS
ACGOD
ACJLH
ACNCT
ACPRK
ACPVT
ACRZS
ACTDY
ACVYA
ADBBV
ADCBC
AENEX
AETEA
AFDAS
AFFDN
AFFNX
AFKRA
AFMIJ
AGNAY
AHMBA
AHVBC
AIKQT
AJJEV
AJUXI
AJYGW
ALMA_UNASSIGNED_HOLDINGS
AN0
AQUVI
AZQEC
BBAFP
BBNVY
BCU
BENPR
BHPHI
BKEYQ
BKNYI
BNQBC
BPHCQ
BVXVI
C45
CJ0
CO
CS3
DCD
DU5
DWQXO
DZ
EBS
EJD
ET
EX3
F5P
FD8
FM.
FYUFA
G8K
GJ
GNUQQ
GUQSH
HCIFZ
HZ
IH2
J5H
K-O
K78
KM
KOO
L7B
LK8
M0R
M0T
M1P
M2M
M2O
M2P
M7P
MBDVC
MVM
N9A
NEJ
NHB
O0-
O9-
OHM
OHT
OK1
OMK
OVD
P-O
P2P
PADUT
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
QZG
RHI
RWL
RXW
S6N
SJFOW
SJN
TAE
TAF
TN5
TWZ
U1N
UCV
UHB
UKR
VQA
W2G
WH7
WOW
X
X7M
XFK
XJT
XZL
YCJ
YHZ
YNT
YQJ
YZZ
ZA5
ZGI
ZHY
ZKB
ZKG
ZXP
---
-DZ
-ET
-~X
.-4
.55
.CO
.GJ
0R~
1CY
29N
36B
39C
41~
68V
6TJ
9M8
AAJWC
AAMNW
AAUGY
AAYOK
ABCQX
ABEFU
ACKOT
ACPFK
ADRHT
AFHKK
AFOSN
AGFXO
AGHSJ
AKALU
CCPQU
D0S
F20
FA8
H13
HF~
HZ~
I4R
IQODW
MQT
N4W
NAPCQ
PCD
PSYQQ
QJJ
S10
SKT
TEORI
TUQ
UBX
UKHRP
UMD
UQL
WHG
WOQ
XOL
XYN
YFH
YQI
YR2
YRY
YYP
YYQ
ZCA
ZR0
ZVN
~KM
ABBLC
ADUKH
AERZD
ALIPV
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
0TZ
7XB
BEC
K0Y
Q9U
7T3
7TO
8FD
FR3
H94
P64
RC3
7X8
ID FETCH-LOGICAL-c535t-3ed5c49bee1de8ef54419822d60fd78a99074ce0839ea6ad3b228683228731613
IEDL.DBID 7X7
ISSN 0028-4793
IngestDate Fri Aug 16 23:42:20 EDT 2024
Sat Oct 05 06:05:20 EDT 2024
Tue Sep 24 23:27:24 EDT 2024
Tue Sep 24 20:38:10 EDT 2024
Thu Sep 26 18:31:43 EDT 2024
Sat Sep 28 07:26:08 EDT 2024
Sun Oct 29 17:09:22 EDT 2023
Wed Nov 11 00:32:51 EST 2020
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 20
Keywords Human
Sarcoma
Germ line
Cytogenetics
Mutation
Malignant tumor
Molecular biology
Suppressor gene
Carcinogenesis
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c535t-3ed5c49bee1de8ef54419822d60fd78a99074ce0839ea6ad3b228683228731613
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Case Study-3
ObjectType-Article-1
ObjectType-Feature-4
ObjectType-Report-2
OpenAccessLink https://www.nejm.org/doi/pdf/10.1056/NEJM199205143262001?articleTools=true
PMID 1565143
PQID 1983448847
PQPubID 40644
PageCount 8
ParticipantIDs proquest_miscellaneous_72892643
proquest_miscellaneous_16675834
proquest_journals_223947857
proquest_journals_1983448847
crossref_primary_10_1056_NEJM199205143262001
pubmed_primary_1565143
pascalfrancis_primary_4353637
mms_nejm_10_1056_NEJM199205143262001
ProviderPackageCode DCD
7FN
PublicationCentury 1900
PublicationDate 1992-05-14
PublicationDateYYYYMMDD 1992-05-14
PublicationDate_xml – month: 05
  year: 1992
  text: 1992-05-14
  day: 14
PublicationDecade 1990
PublicationPlace Boston, MA
PublicationPlace_xml – name: Boston, MA
– name: United States
– name: Boston
PublicationTitle The New England journal of medicine
PublicationTitleAlternate N Engl J Med
PublicationYear 1992
Publisher Massachusetts Medical Society
Publisher_xml – name: Massachusetts Medical Society
References (r005) 1988; 48
(r028) 1987; 7
(r035) 1991; 83
(r008) 1990; 249
(r024) 1977; 74
(r013) 1987; 84
(r034) 1991; 51
(r009) 1988; 3
(r011) 1989; 57
(r029) 1990; 50
(r004) 1990; 348
Takebe H, Utsunomiya J, eds. Genetics of human tumors in Japan. Gann monograph on cancer research no. 35. Tokyo: Japan Scientific Societies Press, 1988.
(r003) 1990; 250
(r014) 1989; 342
(r023) 1991; 88
(r001) 1985; 45
(r027) 1989; 45
(r016) 1990; 87
(r017) 1990; 108
(r022) 1990; 5
(r018) 1985; 313
(r031) 1988; 62
(r020) 1985; 314
(r012) 1990; 249
(r002) 1979; 52
(r006) 1979; 278
(r019) 1990; 8
(r021) 1989; 63
(r007) 1990; 249
(r030) 1991; 65
(r032) 1984; 91
(r010) 1991; 252
(r025) 1985; 230
(r015) 1989; 86
(r026) 1989; 5
1565147 - N Engl J Med. 1992 May 14;326(20):1350-2
Abramson (r032) 1984; 91
r020
Baker (r029) 1990; 50
r023
Tamboli (r017) 1990; 108
Iguchi-Ariga (r009) 1988; 3
Knudson (r001) 1985; 45
r018
r013
r035
r014
r015
r016
Li (r005) 1988; 48
Matlashewski (r028) 1987; 7
Tamura (r034) 1991; 51
r010
r011
Yandell (r027) 1989; 45
r033
r012
Crist (r019) 1990; 8
r030
r006
r007
r008
r002
r024
Kraiss (r031) 1988; 62
r003
r025
r004
r026
Hinds (r021) 1989; 63
Soussi (r022) 1990; 5
References_xml – volume: 52
  start-page: 1
  year: 1979
  ident: r002
  article-title: Genetics of retinoblastoma
  publication-title: Hum Genet
– volume: 87
  start-page: 5863
  year: 1990
  ident: r016
  article-title: Mechanisms of p53 loss in human sarcomas
  publication-title: Proc Natl Acad Sci U S A
– volume: 50
  start-page: 7717
  year: 1990
  ident: r029
  article-title: p53 Gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis
  publication-title: Cancer Res
– volume: 314
  start-page: 633
  year: 1985
  ident: r020
  article-title: Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus
  publication-title: Nature
– volume: 108
  start-page: 128
  year: 1990
  ident: r017
  article-title: The incidence of retinoblastoma in the United States: 1974 through 1985
  publication-title: Arch Ophthalmol
– volume: 74
  start-page: 1245
  year: 1977
  ident: r024
  article-title: Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants
  publication-title: Proc Natl Acad Sci USA
– volume: 278
  start-page: 261
  year: 1979
  ident: r006
  article-title: T antigen is bound to a host protein in SV40-transformed cells
  publication-title: Nature
– volume: 249
  start-page: 1049
  year: 1990
  ident: r008
  article-title: Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene
  publication-title: Science
– volume: 57
  start-page: 1083
  year: 1989
  ident: r011
  article-title: The p53 proto-oncogene can act as a suppressor of transformation
  publication-title: Cell
– volume: 230
  start-page: 1350
  year: 1985
  ident: r025
  article-title: Enzymatic amplification of betaglobin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia
  publication-title: Science
– volume: 342
  start-page: 705
  year: 1989
  ident: r014
  article-title: Mutations in the p53 gene occur in diverse human tumour types
  publication-title: Nature
– volume: 83
  start-page: 93843
  year: 1991
  ident: r035
  article-title: Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines
  publication-title: J Natl Cancer Inst
– volume: 5
  start-page: 945
  year: 1990
  ident: r022
  article-title: Structural aspects of the p53 protein in relation to gene evolution
  publication-title: Oncogene
– volume: 249
  start-page: 912
  year: 1990
  ident: r012
  article-title: Suppression of human colorectal carcinoma cell growth by wild-type p53
  publication-title: Science
– volume: 348
  start-page: 747
  year: 1990
  ident: r004
  article-title: Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li—Fraumeni syndrome
  publication-title: Nature
– volume: 48
  start-page: 5358
  year: 1988
  ident: r005
  article-title: A cancer family syndrome in twenty-four kindreds
  publication-title: Cancer Res
– volume: 313
  start-page: 1637
  year: 1985
  ident: r018
  article-title: Osteosarcoma: fifteen years later
  publication-title: N Engl J Med
– volume: 62
  start-page: 4737
  year: 1988
  ident: r031
  article-title: Oligomerization of oncoprotein p53
  publication-title: J Virol
– volume: 5
  start-page: 874
  year: 1989
  ident: r026
  article-title: Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction
  publication-title: Genomics
– volume: 45
  start-page: 547
  year: 1989
  ident: r027
  article-title: Detection of DNA sequence polymorphisms by enzymatic amplification and direct genomic sequencing
  publication-title: Am J Hum Genet
– volume: 8
  start-page: 443
  year: 1990
  ident: r019
  article-title: Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II
  publication-title: J Clin Oncol
– volume: 63
  start-page: 739
  year: 1989
  ident: r021
  article-title: Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation
  publication-title: J Virol
– volume: 45
  start-page: 1437
  year: 1985
  ident: r001
  article-title: Hereditary cancer, oncogenes, and antioncogenes
  publication-title: Cancer Res
– volume: 252
  start-page: 1708
  year: 1991
  ident: r010
  article-title: Identification of p53 as a sequence-specific DNA-binding protein
  publication-title: Science
– volume: 88
  start-page: 7825
  year: 1991
  ident: r023
  article-title: Identification of a germ-line mutation in the p53 gene in a patient with intracranial ependymoma
  publication-title: Proc Natl Acad Sci U S A
– volume: 249
  start-page: 1046
  year: 1990
  ident: r007
  article-title: Presence of a potent transcription activating sequence in the p53 protein
  publication-title: Science
– volume: 84
  start-page: 7716
  year: 1987
  ident: r013
  article-title: Rearrangement of the p53 gene in human osteogenic sarcomas
  publication-title: Proc Natl Acad Sci U S A
– volume: 7
  start-page: 961
  year: 1987
  ident: r028
  article-title: Primary structure polymorphism at amino acid residue 72 of human p53
  publication-title: Mol Cell Biol
– volume: 51
  start-page: 3056
  year: 1991
  ident: r034
  article-title: Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis
  publication-title: Cancer Res
– volume: 250
  start-page: 1233
  year: 1990
  ident: r003
  article-title: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms
  publication-title: Science
– volume: 86
  start-page: 6783
  year: 1989
  ident: r015
  article-title: Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia
  publication-title: Proc Natl Acad Sci U S A
– volume: 65
  start-page: 765
  year: 1991
  ident: r030
  article-title: Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation
  publication-title: Cell
– volume: 91
  start-page: 1351
  year: 1984
  ident: r032
  article-title: Second nonocular tumors in retinoblastoma survivors: are they radiation-induced?
  publication-title: Ophthalmology
– volume: 3
  start-page: 509
  year: 1988
  ident: r009
  article-title: Cloning of the p53-dependent origin of cellular DNA replication
  publication-title: Oncogene
– volume: 48
  start-page: 5358
  year: 1988
  ident: r005
  publication-title: Cancer Res
  contributor:
    fullname: Li
– volume: 7
  start-page: 961
  year: 1987
  ident: r028
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.7.2.961
  contributor:
    fullname: Matlashewski
– ident: r004
  doi: 10.1038/348747a0
– volume: 3
  start-page: 509
  year: 1988
  ident: r009
  publication-title: Oncogene
  contributor:
    fullname: Iguchi-Ariga
– volume: 91
  start-page: 1351
  year: 1984
  ident: r032
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(84)34127-6
  contributor:
    fullname: Abramson
– ident: r006
  doi: 10.1038/278261a0
– ident: r003
  doi: 10.1126/science.1978757
– ident: r025
  doi: 10.1126/science.2999980
– ident: r008
  doi: 10.1126/science.2144364
– volume: 50
  start-page: 7717
  year: 1990
  ident: r029
  publication-title: Cancer Res
  contributor:
    fullname: Baker
– ident: r030
  doi: 10.1016/0092-8674(91)90384-B
– ident: r018
  doi: 10.1056/NEJM198512263132605
– volume: 8
  start-page: 443
  year: 1990
  ident: r019
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.1990.8.3.443
  contributor:
    fullname: Crist
– ident: r020
  doi: 10.1038/314633a0
– volume: 63
  start-page: 739
  year: 1989
  ident: r021
  publication-title: J Virol
  doi: 10.1128/JVI.63.2.739-746.1989
  contributor:
    fullname: Hinds
– volume: 5
  start-page: 945
  year: 1990
  ident: r022
  publication-title: Oncogene
  contributor:
    fullname: Soussi
– volume: 51
  start-page: 3056
  year: 1991
  ident: r034
  publication-title: Cancer Res
  contributor:
    fullname: Tamura
– ident: r026
  doi: 10.1016/0888-7543(89)90129-8
– ident: r033
– ident: r023
  doi: 10.1073/pnas.88.17.7825
– volume: 108
  start-page: 128
  year: 1990
  ident: r017
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.1990.01070030134045
  contributor:
    fullname: Tamboli
– volume: 45
  start-page: 547
  year: 1989
  ident: r027
  publication-title: Am J Hum Genet
  contributor:
    fullname: Yandell
– ident: r016
  doi: 10.1073/pnas.87.15.5863
– ident: r007
  doi: 10.1126/science.2144363
– ident: r014
  doi: 10.1038/342705a0
– ident: r013
  doi: 10.1073/pnas.84.21.7716
– ident: r010
  doi: 10.1126/science.2047879
– ident: r011
  doi: 10.1016/0092-8674(89)90045-7
– volume: 62
  start-page: 4737
  year: 1988
  ident: r031
  publication-title: J Virol
  doi: 10.1128/JVI.62.12.4737-4744.1988
  contributor:
    fullname: Kraiss
– volume: 45
  start-page: 1437
  year: 1985
  ident: r001
  publication-title: Cancer Res
  contributor:
    fullname: Knudson
– ident: r015
  doi: 10.1073/pnas.86.17.6783
– ident: r012
  doi: 10.1126/science.2144057
– ident: r002
  doi: 10.1007/BF00295569
– ident: r035
  doi: 10.1093/jnci/83.13.938
– ident: r024
  doi: 10.1073/pnas.74.3.1245
SSID ssj0000149
Score 1.929447
Snippet HEREDITARY mutations of tumor-suppressor genes have been correlated with a genetic predisposition to cancer, and several such genes have been linked to...
Recent studies have identified germline mutations of the p53 tumor-suppressor gene in families with the Li-Fraumeni syndrome, a rare inherited disorder...
Abstract Background Recent studies have identified germline mutations of the p53 tumor-suppressor gene in families with the Li--Fraumeni syndrome, a rare...
We studied DNA from peripheral leukocytes of 196 patients with sarcoma and from 200 controls. Of the 196 patients with sarcoma, 15 were selected because they...
BACKGROUNDRecent studies have identified germline mutations of the p53 tumor-suppressor gene in families with the Li-Fraumeni syndrome, a rare inherited...
SourceID proquest
crossref
pubmed
pascalfrancis
mms
SourceType Aggregation Database
Index Database
Publisher
StartPage 1301
SubjectTerms Adolescent
Adult
Age Factors
Amino acids
Base Sequence
Biological and medical sciences
Bone cancer
Bone tumors
Brain cancer
Breast cancer
Cancer
Cell cycle
Child
Codon
Codons
Cross-Sectional Studies
Deoxyribonucleic acid
DNA
Family medical history
Female
Genes
Genes, p53
Genetic testing
Genetics
Heterozygote
Humans
Infant
Japan - epidemiology
Leukocytes
Male
man
Medical sciences
Molecular Sequence Data
Mutation
Neoplastic Syndromes, Hereditary - epidemiology
Neoplastic Syndromes, Hereditary - genetics
Osteosarcoma - genetics
p53 gene
p53 Protein
Patients
Polymorphism, Genetic
Sarcoma
Sarcoma - epidemiology
Sarcoma - genetics
Splice junctions
tumor suppressor genes
Tumors
United States - epidemiology
Title Prevalence and Spectrum of Germline Mutations of the p53 Gene among Patients with Sarcoma
URI http://dx.doi.org/10.1056/NEJM199205143262001
https://www.ncbi.nlm.nih.gov/pubmed/1565143
https://www.proquest.com/docview/1983448847/abstract/
https://www.proquest.com/docview/223947857/abstract/
https://search.proquest.com/docview/16675834
https://search.proquest.com/docview/72892643
Volume 326
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwEB7BIqFeEI-ihqcPHBvtxq8kp2pBPIS0aEVB2p4ix3YOSElos_v_O5PH0qqFSw6byBvbM_Y3M873AVxIGeeRRUfiZmJCaVOL6yBXoVSF9D5PuTGU0J896Ltneb9Qiw24Hb6FoWOVw5rYLtSutpQjH3PS8I4TjN9NTkkAuxx_e_0ZknwUlVl7LY1N2Io4ogo07HgR_8Ej1ePgPpU00A8pPSbJeTqCSTzggtjZe3mYYYvaLMuGDkyaBses6MQu3kej7a50sws7PZxk027-92DDV_uwPesL5gfwgyiaTPthETOVYyQ3v_y1KlldsFtclAlkstmqq8c39CsCQjZXghEfNZuSFBGbd9yrDaOkLfuOrlGX5jM831w_Xd2FvZpCaJVQy1B4p6xMc-8j5xNfkPgYkfc5PSlcnJiUwmTrcfBSb7RxIuc80eTwCalbReIQRlVd-S_AImeJdCeXBW5ukvNcGMENNqwnruBaBPB1GMDstSPNyNpit9LZf8Y7gAsc5KzyL-XHj53-NQvrphHxCS3iAE6GWcl6R2wy7KLACBT34ACO_729tqoAztd30cGoamIqX6-wBU0xlZDvPxFj0Iq4Ert92NnCW6cRLuP7H33418fwqTsDrMJInsAIrcCfItJZ5metFeM1uYrOYOvy-mH--Bv9RPdc
link.rule.ids 315,786,790,12083,12250,21416,27957,27958,31754,31755,33301,33302,33779,33780,43345,43614,43840,74102,74371,74659
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwEB4BlVouiNKipizFB46N2PiV5FStUOnyWIQESPQUObFzqJRkIbv_n5nEWUAFrnHkxI_xfPaMvw_gUMo4jwo0JG7GJpRFWuA6yFUoVSmdy1NuDB3ozy719Fae3ak7n5vT-rTKYU3sFmrbFHRGfsRJwztOVPxrfh-SaBQFV72Cxjp8kAL9DF0UP46esUd59OsPkAbSIaWPSGieEi-J_VsQJ7sXhRkc03pVtZQmaVrsqbKXuHgbg3a-6GQbtjyIZJN-1D_Dmqt34OPMh8m_wF8iZjLddSJmastIZH7xsKxYU7I_uBQTtGSzZR-Fb-kpwkB2pQQjFmo2IQEidtUzrraMjmrZNRpEU5mvcHvy--Z4GnoNhbBQQi1C4awqZJo7F1mXuJIkx4iyz-pxaePEpLQ5LhwCsdQZbazIOU80mXlCmlaR2IWNuqndN2CRLYhqJ5clujTJeS6M4AYr1mNbci0C-Dl0YDbvqTKyLsStdPZKfwdwiJ2c1e5f9f5r-y9GYVU14jyhRRzAaBiVzJtfm2ETBe470fMGsPd_8WouBXCwKkWzoliJqV2zxBo07aSEfPuNGLeqiCax2bv9XHhqNIJk_P_v7376AD5Nb2YX2cXp5fkebPZZwCqM5Ag2cEa4fcQ6i_xHN6MfAb6R8_M
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwEB4VKiEuCEoRKS8fOBKx8SvJCaG2C21ZtFKLtD1FTuwckJIsze7_ZyZxtiAe1yTyxs6M5xvP7PcBnEoZ51GBjsTNyISySAvcB7kKpSqlc3nKjaED_cmtvr6TP2dq5imFWt9WOeyJ3UZtm4LOyM85aXjHCebvpe-KmH4bX8wfQhKQokKrV9NYg48YJEckZhDP4idMUh4J-8OkgYBI6XMSnacmTGICF8TP7gVihiC1VlUttUyaFlet7OUu3sajXVwab8OWB5TssreAHfjg6k-wMfEl8134SyRNpvtrETO1ZSQ4v_i3rFhTsivclglmssmyr8i3dBUhIZsqwYiRml2SGBGb9uyrLaNjW_YbnaOpzGe4G3__8_U69HoKYaGEWoTCWVXINHcusi5xJcmPEX2f1aPSxolJKVEuHIKy1BltrMg5TzS5fEL6VpHYg_W6qd0-sMgWRLuTyxLDm-Q8F0ZwgwPrkS25FgGcDQuYzXvajKwrdyudvbLeAZziIme1u6_ef-zo2VdYDY2YT2gRB3A4fJXMu2Kb4RQF5qAYhQM4eHl7ZVcBnKzuootR3cTUrlniCJqyKiHffiLGtBWRJU57r7eF_5NGwIzv_-Xdnz6BDTTm7ObH7a8D2OwbglUYyUNYR4NwRwh7FvlxZ9CP0V74VA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+and+spectrum+of+germline+mutations+of+the+p53+gene+among+patients+with+sarcoma&rft.jtitle=The+New+England+journal+of+medicine&rft.au=Toguchida%2C+J&rft.au=Yamaguchi%2C+T&rft.au=Dayton%2C+SH&rft.au=Beauchamp%2C+R+L&rft.date=1992-05-14&rft.issn=0028-4793&rft.volume=326&rft.issue=20&rft.spage=1301&rft.epage=1308&rft_id=info:doi/10.1056%2FNEJM199205143262001&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0028-4793&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0028-4793&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0028-4793&client=summon